Tempest Therapeutics (NASDAQ: TPST), a clinical-stage biotechnology firm focused on innovative cancer therapies, announced a significant milestone on Thursday as…
Read More »Biotech
In a significant advancement for the field of genomic medicine, Sangamo Therapeutics has entered a landmark license agreement with Genentech,…
Read More »
In a remarkable turn of events, Altimmune (NASDAQ: ALT) witnessed a staggering 27% surge in its stock price this morning,…
Read More »
Gilead Sciences (NASDAQ: GILD) witnessed a notable 4% surge in its stock price this morning, driven by a confluence of…
Read More »
Shares of Day One Biopharmaceuticals (NASDAQ: DAWN) surged 11.3% this morning, reflecting strong investor confidence fueled by a series of…
Read More »
Company Overview Intra-Cellular Therapies (NASDAQ: ITCI) is a biopharmaceutical company focused on the development of therapeutics for central nervous system…
Read More »
CRISPR Therapeutics (NASDAQ: CRSP) saw a notable increase in its stock price, rising by 3.6% even though there was no…
Read More »
Avidity Biosciences (NASDAQ: RNA) has seen a significant surge in its stock price, opening nearly 5% higher today. This increase…
Read More »
Vanda Pharmaceuticals (NASDAQ: VNDA) stock is experiencing a significant increase in early trading following two notable announcements. The first involves…
Read More »
MindMed, a company specializing in psychedelic medicine, experienced a significant drop in its stock price, falling 15% following news regarding…
Read More »